全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

我国年轻乳腺癌现状分析
Analysis of the Current Situation of Young Breast Cancer in China

DOI: 10.12677/ACM.2023.1361465, PP. 10468-10475

Keywords: 年轻乳腺癌,病理特征,雌激素受体,孕激素受体,生育
Young Breast Cancer
, Pathological Features, Estrogen Receptor, Progesterone Receptor, Fertility

Full-Text   Cite this paper   Add to My Lib

Abstract:

随着体检的普及和诊疗技术的提高,越来越多的早期乳腺癌能被确诊,当代年轻人随着精神压力、工作生活以及遗传等因素,乳腺癌逐渐年轻化,这就给未婚未孕或有生育需求女性带来了一系列问题。例如标准化抗肿瘤治疗会对生育造成不可逆性损伤、治疗时间过长错过生育最佳年龄,以及乳腺手术给女性身体及心理造成的不良影响。本文主要针对年轻乳腺癌目前的诊断、防治、生育等方面进行综述。
With the popularization of medical checkups and the improvement of treatment technology, more and more breast cancers can be diagnosed early. With the mental stress, work life and genetic fac-tors, breast cancer is gradually becoming younger among young people today, which brings a series of problems to unmarried women who are not pregnant or have fertility needs. For example, stand-ardized anti-tumor treatment can cause irreversible damage to fertility, prolonged treatment time misses the optimal age for childbirth, and the adverse physical and psychological effects of breast surgery on women. This article focuses on a review of the current aspects of diagnosis, prevention and treatment, and fertility in young breast cancer.

References

[1]  Huang, J.J., Chan, P.S., Lok, V., Chen, X., Ding, H.Y., Jin, Y.Z., Yuan, J.Q. and Lao, X.-Q. (2021) Global Incidence and Mortality of Breast Cancer: A Trend Analysis. Aging (Albany NY), 13, 5748-5803.
https://doi.org/10.18632/aging.202502
[2]  Sung, H. (2021) Global Cancer Statistics 2020: GLOBOCAN Esti-mates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
[3]  中国年轻乳腺癌诊疗与生育管理专家共识专家委员会. 年轻乳腺癌诊疗与生育管理专家共识[J]. 中华肿瘤杂志, 2019, 41(7): 486-495.
[4]  Ribnikar, D. and Ribeiro, J.M. (2015) Breast Cancer under Age 40: A Different Approach. Current Treatment Options in Oncology, 16, Article No. 334.
https://doi.org/10.1007/s11864-015-0334-8
[5]  Johansson Anna, L.V. (2019) Breast Cancer-Specific Sur-vival by Clinical Subtype after 7 Years Follow-Up of Young and Elderly Women in a Nationwide Cohort. International Journal of Cancer, 144, 1251-1261.
https://doi.org/10.1002/ijc.31950
[6]  赵建芳, 李延新. 年轻乳腺癌患者与中老年乳腺癌患者在临床病理中的差异对比[J]. 延安大学学报(医学科学版), 2018, 16(2): 65-67.
[7]  Eiriz, I.F., Vaz Batista, M., Cruz Tomás, T., Neves, M.T., Guerra-Pereira, N. and Braga, S. (2021) Breast Cancer in Very Young Women—A Multicenter 10-Year Experience. ESMO Open, 6, Article ID: 100029.
https://doi.org/10.1016/j.esmoop.2020.100029
[8]  中国抗癌协会乳腺癌专业委员会. 中国乳腺癌筛查与早期诊断指南[J]. 中国癌症杂志, 2022, 32(4): 363-372.
[9]  杨晶, 黄安茜, 谭艳娟, 朱罗茜, 包凌云. 超声多模态在年轻乳腺癌中的诊断价值[J]. 浙江中西医结合杂志, 2021, 31(12): 1144-1146, 1182.
[10]  乌兰, 陈宁, 朱晓龙. X线钼靶、CT检测及超声检测致密型腺体乳腺癌早期诊断中的应用价值对比[J]. 中国CT和MRI杂志, 2021, 19(10): 87-90.
[11]  吴丽伟. 超声诊断技术在乳腺癌早期诊断中的应用及准确性分析[J]. 影像研究与医学应用, 2022, 6(9): 148-150.
[12]  汪瑞, 周军, 沈俊, 董天赋, 王培顺, 高希涛, 李淑琴, 王岩, 王昭昕. 核磁共振成像, X线钼靶及彩色超声在乳腺癌早期诊断中的应用价值分析[J]. 世界最新医学信息文摘, 2017, 17(75): 128-129.
[13]  王鑫. 青年乳腺癌临床病理特点分子分型及预后分析[J]. 现代诊断与治疗, 2020, 31(22): 3603-3605.
[14]  Zhong, W.J., Tan, L.Y., Jiang, W.G., Chen, K., You, N., Sanders, A.J., Liang, G.H. and Liu, Z.H. (2019) Effect of Younger Age on Survival Outcomes in T1N0M0 Breast Cancer: A Propensity Score Matching Analysis. Journal of Surgical On-cology, 119, 1039-1046.
https://doi.org/10.1002/jso.25457
[15]  Anders, C.K., Fan, C., Parker, J.S., Carey, L.A., Blackwell, K.L. and Klauber-DeMore, N. (2011) Breast Carcinomas Arising at a Young Age: Unique Biology or a Sur-rogate for Aggressive Intrinsic Subtypes? Journal of Clinical Oncology, 29, e18-e20.
https://doi.org/10.1200/JCO.2010.28.9199
[16]  Yang, Y.P., Wei, W.D., Jin, L., He, H.Y., Wei, M.N., Shen, S.Y., Pi, H., Liu, Z.Q. and Li, H.Y. (2022) Comparison of the Characteristics and Prognosis between Very Young Women and Older Women with Breast Cancer: A Multi-Institutional Report From China. Frontiers in Oncology, 12, Article ID: 783487.
https://doi.org/10.3389/fonc.2022.783487
[17]  李宏, 胡波. 探讨超声引导下粗针穿刺活检在乳腺癌诊疗中的应用价值[J]. 中国医药指南, 2020, 18(32): 32-34.
[18]  Perou, C.M., S?rlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T. and Johnsen, H. (2000) Molecular Portraits of Human Breast Tumours. Na-ture, 406, 747-752.
https://doi.org/10.1038/35021093
[19]  Goldhirsch, A., Winer, E.P., Coates, A.S., Gelber, R.D., Piccart-Gebhart, M., Thürlimann, B. and Senn, H.-J. (2013) Personalizing the Treatment of Women with Early Breast Cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Annals of Oncology, 24, 2206-2223.
[20]  Coates, A.S., Winer, E.P., Goldhirsch, A., Gelber, R.D., Gnant, M., Pic-cart-Gebhart, M., Thürlimann, B. and Senn, H.-J. (2015) Tailoring Therapies—Improving the Management of Early Breast Cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Annals of Oncology, 26, 1533-1546.
[21]  冷茹冰, 张新阁, 周红艳, 李娜. 不同分子分型乳腺癌的临床病理特征及预后危险因素分析[J]. 临床医学, 2021, 41(5): 8-10.
[22]  Ehinger, A., Malmstr?m, P., Bendahl, P.-O., Elston, C.W., Falck, A.-K. and Forsare, C. (2017) Histological Grade Provides Significant Prognostic Information in Addition to Breast Can-cer Subtypes Defined According to St Gallen 2013. Acta Oncologica, 56, 68-74.
https://doi.org/10.1080/0284186X.2016.1237778
[23]  Xue, C., Wang, X., Peng, R.J., Shi, Y.X., Qin, T., Liu, D.G., Teng, X.Y., Wang, S.S. and Zhang, L. (2012) Distribution, Clinicopathologic Features and Survival of Breast Cancer Subtypes in Southern China. Cancer Science, 103, 1679-1687.
https://doi.org/10.1111/j.1349-7006.2012.02339.x
[24]  吕爱红. 浅谈年轻女性乳腺癌的临床病理特征及分子分型[J]. 世界复合医学, 2018, 4(3): 5-7.
[25]  Maffuz-Aziz, A., Labastida-Almendaro, S., Espejo-Fonseca, A. and Rodríguez-Cuevas, S. (2017) Clinical and Pathological Features of Breast Cancer in a Population of Mexico. Cirugía y Cirujanos, 85, 201-207.
https://doi.org/10.1016/j.circen.2017.05.010
[26]  胡震, 朱信屹. 乳腺癌的预防[J]. 实用肿瘤杂志, 2016, 31(5): 409-414.
[27]  Kolak, A., Kamińska, M., Sygit, K., Budny, A. and Surdyka, D. (2017) Primary and Secondary Preven-tion of Breast Cancer. Annals of Agricultural and Environmental Medicine, 24, 549-553.
https://doi.org/10.26444/aaem/75943
[28]  Sellami, M. and Bragazzi, N.L. (2020) Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention. Nutrients, 12, Article No. 512.
https://doi.org/10.3390/nu12020512
[29]  Feng, F., Wei, Y.X., Zheng, K., Li, Y.J., Zhang, L., Wang, T.L., Zhang, Y.L. and Li, H.Y. (2018) Comparison of Epidemiological Features, Clinicopathological Features, and Treatments be-tween Premenopausal and Postmenopausal Female Breast Cancer Patients in Western China: A Retrospective Multicenter Study of 15,389 Female Patients. Cancer Medicine, 7, 2753-2763.
https://doi.org/10.1002/cam4.1503
[30]  Borges, V.F., Lyons, T.R., Germain, D. and Schedin, P. (2020) Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments? Cancer Research, 80, 1790-1798.
https://doi.org/10.1158/0008-5472.CAN-19-3448
[31]  李培, 吴炅. 中国乳腺癌外科治疗现状和新趋势[J]. 中国肿瘤临床, 2022, 49(22): 1151-1155.
[32]  Komoike, Y., Akiyama, F., Iino, Y., Ikeda, T., Akashi-Tanaka, S. and Ohsumi, S. (2006) Ipsilateral Breast Tumor Recurrence (IBTR) after Breast-Conserving Treatment for Early Breast Can-cer: Risk Factors and Impact on Distant Metastases. Cancer, 106, 35-41.
https://doi.org/10.1002/cncr.21551
[33]  Litière, S., Werutsky, G., Fentiman, I.S., Rutgers, E. and Christiaens, M.-R. (2012) Breast Conserving Therapy versus Mastectomy for Stage I-II Breast Cancer: 20 Year Follow-Up of the EORTC 10801 Phase 3 Randomised Trial. The Lancet Oncology, 13, 412-419.
https://doi.org/10.1016/S1470-2045(12)70042-6
[34]  Lowery, A.J., Kell, M.R., Glynn, R.W., Kerin, M.J. and Sweeney, K.J. (2012) Locoregional Recurrence after Breast Cancer Surgery: A Systematic Review by Receptor Pheno-type. Breast Cancer Research and Treatment, 133, 831-841.
https://doi.org/10.1007/s10549-011-1891-6
[35]  Peyroteo, M., Canotilho, R., Correia, A.M., Baía, C., Ribeiro, C. and Reis, P. (2022) Predictive Factors of Non-Sentinel Lymph Node Disease in Breast Cancer Patients with Positive Sentinel Lymph Node. Cirugía Espa?ola (English Edition), 100, 81-87.
https://doi.org/10.1016/j.cireng.2022.01.003
[36]  Krag, D.N. anderson, S.J., Julian, T.B., Brown, A.M., Harlow, S.P. and Costantino, J.P. (2010) Sentinel-Lymph-Node Resection Compared with Conventional Axillary-Lymph-Node Dissection in Clinically Node-Negative Patients with Breast Cancer: Overall Survival Findings from the NSABP B-32 Randomised Phase 3 Trial. The Lancet Oncology, 11, 927-933.
https://doi.org/10.1016/S1470-2045(10)70207-2
[37]  Miseré, R., van Kuijk, S., Claassens, E.L., Heuts, E.M., Pi-atkowski, A.A. and van der Hulst, R. (2021) Breast-Related and Body-Related Quality of Life Following Autologous Breast Reconstruction Is Superior to Implant-Based Breast Reconstruction—A Long-Term Follow-Up Study. Breast, 59, 176-182.
https://doi.org/10.1016/j.breast.2021.07.003
[38]  Liu, J., Zheng, X., Lin, S., Han, H. and Xu, C. (2022) A Systematic Review and Meta-Analysis on the Prepectoral Single-Stage Breast Reconstruction. Supportive Care in Cancer, 30, 5659-5668.
https://doi.org/10.1007/s00520-022-06919-5
[39]  Cao, W., Xie, Y.T., He, Y.J., Li, J.F., Wang, T.F., Fan, Z.Q., Fan, T. and Ouyang, T. (2019) Risk of Ipsilateral Breast Tumor Recurrence in Primary Invasive Breast Cancer Following Breast-Conserving Surgery with BRCA1 and BRCA2 Mutation in China. Breast Cancer Research and Treatment, 175, 749-754.
https://doi.org/10.1007/s10549-019-05199-8
[40]  Valachis, A., Nearchou, A.D. and Lind, P. (2014) Surgical Management of Breast Cancer in BRCA-Mutation Carriers: A Systematic Review and Meta-Analysis. Breast Cancer Research and Treatment, 144, 443-455.
https://doi.org/10.1007/s10549-014-2890-1
[41]  Wan, Q.T., Su, L.M., Ouyang, T., Li, J.F., Wang, T.F., Fan, Z.Q., Fan, T., Lin, B.Y. and Xie, Y.T. (2021) Comparison of Survival after Breast-Conserving Therapy vs Mastectomy among Patients with or without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients with Breast Cancer. JAMA Network Open, 4, e216259.
https://doi.org/10.1001/jamanetworkopen.2021.6259
[42]  van den Broek, A.J., Schmidt, M.K., van‘t Veer Laura, J., Oldenburg Hester, S.A. and Rutgers, E.J. (2019) Prognostic Impact of Breast-Conserving Therapy versus Mastectomy of BRCA1/2 Mutation Carriers Compared with Noncarriers in a Consecutive Series of Young Breast Cancer Patients. Annals of Surgery, 270, 364-372.
https://doi.org/10.1097/SLA.0000000000002804
[43]  Su, L.M., Xu, Y., Ouyang, T., Li, J.F., Wang, T.F., Fan, Z.Q., Fan, T., Lin, B.Y. and Xie, Y.T. (2020) Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carri-ers in a Large Cohort of Unselected Chinese Breast Cancer Patients. International Journal of Cancer, 146, 3335-3342.
https://doi.org/10.1002/ijc.32918
[44]  McDonnell, S.K., Schaid, D.J., Myers, J.L., Grant, C.S., Donohue, J.H., Woods, J.E., Frost, M.H. and Johnson, J.L. (2001) Efficacy of Contralateral Prophylactic Mastectomy in Women with a Personal and Family History of Breast Cancer. Journal of Clinical Oncology, 19, 3938-3943.
https://doi.org/10.1200/JCO.2001.19.19.3938
[45]  Paluch-Shimon, S. (2022) ESO-ESMO Fifth International Consensus Guidelines for Breast Cancer in Young Women (BCY5). Annals of Oncology, 33, 1097-1118.
https://doi.org/10.1016/j.annonc.2022.07.007
[46]  Burstein, H.J., Lacchetti, C. Anderson, H., Buchholz, T.A., Da-vidson, N.E. and Gelmon, K.A. (2019) Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. Journal of Clinical Oncology, 37, 423-438.
https://doi.org/10.1200/JCO.18.01160
[47]  Gradishar, W.J. (2021) NCCN Guidelines? Insights: Breast Cancer, Version 4.2021. Journal of the National Comprehensive Cancer Network, 19, 484-493.
[48]  Zong, X., et al. (2022) Ef-fects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women with Breast Cancer in China: A Randomized Clinical Trial. JAMA Oncology, 8, 252-258.
[49]  Kummerow, K.L., Du, L., Penson, D.F., Shyr, Y. and Hooks, M.A. (2015) Nationwide Trends in Mas-tectomy for Early-Stage Breast Cancer. JAMA Surgery, 150, 9-16.
https://doi.org/10.1001/jamasurg.2014.2895
[50]  Francis, P.A. (2018) Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. The New England Journal of Medicine, 379, 122-137.
[51]  Francis, P.A. (2015) Adju-vant Ovarian Suppression in Premenopausal Breast Cancer. The New England Journal of Medicine, 372, 436-446.
https://doi.org/10.1056/NEJMc1502618
[52]  Cooke, A., Mills, T.A. and Lavender, T. (2010) “Informed and Un-informed Decision Making”—Women’s Reasoning, Experiences and Perceptions with Regard to Advanced Maternal Age and Delayed Childbearing: A Meta-Synthesis. International Journal of Nursing Studies, 47, 1317-1329.
https://doi.org/10.1016/j.ijnurstu.2010.06.001
[53]  Moragón, S., Di Liello, R., Bermejo, B., Hernando, C., Olcina, E. and Chirivella, I. (2021) Fertility and Breast Cancer: A Literature Review of Counseling, Preservation Options and Outcomes. Critical Reviews in Oncology/Hematology, 166, Article ID: 103461.
https://doi.org/10.1016/j.critrevonc.2021.103461
[54]  白宇鸽, 等. 年轻乳腺癌患者生育能力保护的研究进展[J]. 中华临床医师杂志(电子版), 2021, 15(2): 118-122.
[55]  Ronn, R. and Holzer, H. (2015) Breast Cancer and Fer-tility: An Update. Current Opinion in Supportive and Palliative Care, 9, 285-293.
https://doi.org/10.1097/SPC.0000000000000164
[56]  杜娟, 马飞, 阮祥燕. 乳腺癌患者生育力保护的研究进展[J]. 中国临床医生杂志, 2019, 47(7): 769-771.
[57]  Moran, M.S., Schnitt, S.J., Giuliano, A.E., Harris, J.R., Khan, S.A., Horton, J., et al. (2014) Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. International Journal of Radiation Oncology, Biology, Physics, 88, 553-564.
https://doi.org/10.1016/j.ijrobp.2013.11.012

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133